CYSTIC FIBROSIS FOUNDATION for CYSTIC FIBROSIS FOUNDATION
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Insurance INS
H.R. 3325: ACE Kids Act; all provisions H.R. 3921: HEALTHY KIDS Act; all provisions H.R. 4200: Healthcare Market Certainty and Mandate Relief Act of 2017; all provisions S. 428: ACE Kids Act of 2017; all provisions S. 1827: Keep Kids' Insurance Dependable and Secure (KIDS) Act of 2017; all provisions S. 1835: Lower Premiums Through Reinsurance Act of 2017; all provisions S. 2052: Health Care Market Certainty and Mandate Relief Act; all provisions S. 2507: Improving Choices in Health Care Coverage Act; all provisions No Bill Yet Introduced: Bipartisan Health Care Stabilization Act of 2018; all provisions
| Lobbyist | Covered position, as disclosed |
|---|---|
| ZOE ALDRICH | — |
| DANIEL CRAMER | — |
| MARY B DWIGHT | — |
| DAVID ELIN | — |
| LISA FENG | — |
| EMILY KINGSLAND | — |
| RACHEL KOREN | — |
| STEPHANIE KRENRICH | — |
| PAYDON MILLER | — |
| SARA SINGLETON | — |
| MOLLY VOIGT | — |
Medical/Disease Research/Clinical Labs MED
H. R. 195: Making Further Continuing Appropriations for the Fiscal Year Ending September 30, 2018, and For Other Purposes; provisions related to funding for the Food and Drug Administration, National Institutes of Health, Centers for Disease Control, Agency for Healthcare Research and Quality, Maternal and Child Health Bureau grants, Health Resources and Services Administration, and the Social Security Administration H.R. 1625: Consolidated Appropriations Act, 2018; provisions related to funding for the Food and Drug Administration, National Institutes of Health, Centers for Disease Control, Agency for Healthcare Research and Quality, Maternal and Child Health Bureau grants, Health Resources and Services Administration, and the Social Security Administration H.R. 1892: Bipartisan Budget Act of 2018; provisions related to funding for the Food and Drug Administration, National Institutes of Health, Centers for Disease Control, Agency for Healthcare Research and Quality, Maternal and Child Health Bureau grants, Health Resources and Services Administration, and the Social Security Administration
| Lobbyist | Covered position, as disclosed |
|---|---|
| ZOE ALDRICH | — |
| DANIEL CRAMER | — |
| MARY B DWIGHT | — |
| DAVID ELIN | — |
| LISA FENG | — |
| RACHEL KOREN | — |
| SARA SINGLETON | — |
| MOLLY VOIGT | — |
Health Issues HCR
H.R. 878: Right to Try Act 2017; all provisions H.R. 3325: ACE Kids Act; all provisions H.R. 3921: HEALTHY KIDS Act; all provisions H.R. 4200: Healthcare Market Certainty and Mandate Relief Act of 2017; all provisions H.R. 5247: Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018; all provisions S. 204: Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017; all provisions S. 428: ACE Kids Act of 2017; all provisions S. 1827: Keep Kids' Insurance Dependable and Secure (KIDS) Act of 2017; all provisions S. 1835: Lower Premiums Through Reinsurance Act of 2017; all provisions S. 2052: Health Care Market Certainty and Mandate Relief Act; all provisions S. 2507: Improving Choices in Health Care Coverage Act; all provisions No Bill Yet Introduced: Bipartisan Health Care Stabilization Act of 2018; all provisions
| Lobbyist | Covered position, as disclosed |
|---|---|
| ZOE ALDRICH | — |
| DANIEL CRAMER | — |
| MARY B DWIGHT | — |
| DAVID ELIN | — |
| LISA FENG | — |
| EMILY KINGSLAND | — |
| RACHEL KOREN | — |
| STEPHANIE KRENRICH | — |
| PAYDON MILLER | — |
| SARA SINGLETON | — |
| MOLLY VOIGT | — |
Medicare/Medicaid MMM
H.R. 3325: ACE Kids Act; all provisions S. 428: ACE Kids Act of 2017; all provisions No Bill Yet Introduced: Bipartisan Health Care Stabilization Act of 2018; all provisions
| Lobbyist | Covered position, as disclosed |
|---|---|
| ZOE ALDRICH | — |
| DANIEL CRAMER | — |
| MARY B DWIGHT | — |
| DAVID ELIN | — |
| EMILY KINGSLAND | — |
| RACHEL KOREN | — |
| STEPHANIE KRENRICH | — |
| PAYDON MILLER | — |
| SARA SINGLETON | — |
| MOLLY VOIGT | — |
Budget/Appropriations BUD
H. R. 195: Making Further Continuing Appropriations for the Fiscal Year Ending September 30, 2018, and For Other Purposes; provisions related to funding for the Food and Drug Administration, National Institutes of Health, Centers for Disease Control, Agency for Healthcare Research and Quality, Maternal and Child Health Bureau grants, Health Resources and Services Administration, and the Social Security Administration H.R. 1625: Consolidated Appropriations Act, 2018; provisions related to funding for the Food and Drug Administration, National Institutes of Health, Centers for Disease Control, Agency for Healthcare Research and Quality, Maternal and Child Health Bureau grants, Health Resources and Services Administration, the Social Security Administration and potential inclusion of marketplace stabilization language H.R. 1892: Bipartisan Budget Act of 2018; provisions related to funding for the Food and Drug Administration, National Institutes of Health, Centers for Disease Control, Agency for Healthcare Research and Quality, Maternal and Child Health Bureau grants, Health Resources and Services Administration, the Social Security Administration and potential inclusion of marketplace stabilization language
| Lobbyist | Covered position, as disclosed |
|---|---|
| ZOE ALDRICH | — |
| DANIEL CRAMER | — |
| MARY B DWIGHT | — |
| DAVID ELIN | — |
| LISA FENG | — |
| RACHEL KOREN | — |
| STEPHANIE KRENRICH | — |
| SARA SINGLETON | — |
| MOLLY VOIGT | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.